Table 3:

Clinical outcomes

Local AnesthesiaCSEmergency Conversion to GAGA
Symptomatic intracranial hemorrhage (No.) (%)3 (3.19%)5 (6.58%)1 (4.00%)3 (5.08%)
NIHSS at 24 hr (median) (Q1–Q3)9 (4–16.8)12.5 (6–20.0)19.0 (14.5–42.0)21.0 (15.0–42.0)
Change in NIHSS at 24 hr (median) (Q1–Q3)–3 (–9.75–0.00)–1 (–8.00–4.00)0 (–2.50–21.5)3 (–1.00–9.50)
mRS at 24 hr (median) (Q1–Q3)4 (3–5)5 (3–5)5 (5–5)5 (5-5)
NIHSS at discharge (median) (Q1–Q3)6 (2–11.0)6 (2–13.0)10.5 (6.50–18.2)13.0 (10.0–18.0)
mRS at discharge (median) (Q1–Q3)4 (2–5)4 (2–5)5 (3–5)5 (4–5)
mRS at 90 days (median) (Q1–Q3)a4 (1.50–5)4 (2–6)5 (2–5)5 (4–6)
mRS 0–2 at 90 days (No.) (%)a28 (32.2%)21 (29.2%)7 (28.0%)4 (7.41%)
  • a Data were available for 87/94 patients (local anesthesia),72/76 patients (CS), 25/25 patients (emergency conversion), and 54/59 patients (GA).